Low-grade imported raw materials should be discouraged

Published: 2007-08-22 06:59:00

Updated: 2007-08-22 06:59:00

Some pharmaceutical manufacturers have been shown to import pharmaceutical bulks in low-grade purity, triggering some common types of unfair practices such as price fixing, illicit inducement of customers in the process of delivery and the abuse of patent rights to dominate the market.

Experts...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK